BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 38128177)

  • 1. Effect of metabolic reprogramming on the immune microenvironment in gastric cancer.
    Shang Z; Ma Z; Wu E; Chen X; Tuo B; Li T; Liu X
    Biomed Pharmacother; 2024 Jan; 170():116030. PubMed ID: 38128177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impacts and mechanisms of metabolic reprogramming of tumor microenvironment for immunotherapy in gastric cancer.
    Zhao L; Liu Y; Zhang S; Wei L; Cheng H; Wang J; Wang J
    Cell Death Dis; 2022 Apr; 13(4):378. PubMed ID: 35444235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Tumor Metabolic Reprogramming in Tumor Immunity.
    Zhang X; Song W; Gao Y; Zhang Y; Zhao Y; Hao S; Ni T
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of metabolism on the immune microenvironment of breast cancer.
    Zhou Y; Wang H; Luo Y; Tuo B; Liu X; Li T
    Biochim Biophys Acta Rev Cancer; 2023 Mar; 1878(2):188861. PubMed ID: 36813054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between Metabolic Reprogramming and Immune Regulation in Digestive Tract Tumors.
    Liu J; Wang T; Zhang W; Huang Y; Wang X; Li Q
    Oncol Res Treat; 2024; 47(6):273-286. PubMed ID: 38636467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting lipid metabolism reprogramming of immunocytes in response to the tumor microenvironment stressor: A potential approach for tumor therapy.
    Zhang M; Wei T; Zhang X; Guo D
    Front Immunol; 2022; 13():937406. PubMed ID: 36131916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of lipid metabolic reprogramming in tumor microenvironment.
    Yang K; Wang X; Song C; He Z; Wang R; Xu Y; Jiang G; Wan Y; Mei J; Mao W
    Theranostics; 2023; 13(6):1774-1808. PubMed ID: 37064872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment.
    Zhu Y; Li X; Wang L; Hong X; Yang J
    Front Endocrinol (Lausanne); 2022; 13():988295. PubMed ID: 36046791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumoral lipid metabolic reprogramming as a pro-tumoral regulator in the tumor milieu.
    Wang R; Hu Q; Wu Y; Guan N; Han X; Guan X
    Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188962. PubMed ID: 37541532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation analysis of lipid metabolism genes with the immune microenvironment in gastric cancer and the construction of a novel gene signature.
    Li Y; Chen X; Zhang R; Chen M; Shen J; Wu J; Yu J; Sun Q
    Clin Transl Oncol; 2023 May; 25(5):1315-1331. PubMed ID: 36520384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant lipid metabolism in hepatocellular carcinoma cells as well as immune microenvironment: A review.
    Hu B; Lin JZ; Yang XB; Sang XT
    Cell Prolif; 2020 Mar; 53(3):e12772. PubMed ID: 32003505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA Modifications in Cancer Metabolism and Tumor Microenvironment.
    Qing Y; Wu D; Deng X; Chen J; Su R
    Cancer Treat Res; 2023; 190():3-24. PubMed ID: 38112997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reprogramming of glutamine metabolism and its impact on immune response in the tumor microenvironment.
    Ma G; Zhang Z; Li P; Zhang Z; Zeng M; Liang Z; Li D; Wang L; Chen Y; Liang Y; Niu H
    Cell Commun Signal; 2022 Jul; 20(1):114. PubMed ID: 35897036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MFSD2A potentiates gastric cancer response to anti-PD-1 immunotherapy by reprogramming the tumor microenvironment to activate T cell response.
    Zhang B; Wang CM; Wu HX; Wang F; Chai YY; Hu Y; Wang BJ; Yu Z; Xia RH; Xu RH; Cao XT
    Cancer Commun (Lond); 2023 Oct; 43(10):1097-1116. PubMed ID: 37539769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview: Lipid Metabolism in the Tumor Microenvironment.
    Ma K; Zhang L
    Adv Exp Med Biol; 2021; 1316():41-47. PubMed ID: 33740242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics.
    Jin HR; Wang J; Wang ZJ; Xi MJ; Xia BH; Deng K; Yang JL
    J Hematol Oncol; 2023 Sep; 16(1):103. PubMed ID: 37700339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analyzing the impact of metabolism on immune cells in tumor microenvironment to promote the development of immunotherapy.
    Long Y; Shi H; He Y; Qi X
    Front Immunol; 2023; 14():1307228. PubMed ID: 38264667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinformatics Analysis and Structure of Gastric Cancer Prognosis Model Based on Lipid Metabolism and Immune Microenvironment.
    Chen Y; Yuan H; Yu Q; Pang J; Sheng M; Tang W
    Genes (Basel); 2022 Sep; 13(9):. PubMed ID: 36140749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour-associated macrophages in gastric cancer: From function and mechanism to application.
    Li J; Sun J; Zeng Z; Liu Z; Ma M; Zheng Z; He Y; Kang W
    Clin Transl Med; 2023 Aug; 13(8):e1386. PubMed ID: 37608500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.